Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Willow at a Glance
- What it is
- A non-injection compounded semaglutide option at a flat $299 — with a weak support record behind it
- Medication type
- Compounded only
- Medications offered
- Compounded semaglutide — subcutaneous injection
- Compounded semaglutide — oral/sublingual tablet (not Rybelsus)
- Compounded tirzepatide — subcutaneous injection
- Pricing
- $299/mo compounded semaglutide (injection or oral tablet); tirzepatide from $399/mo, rising with dose
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Willow?
Willow is an Austin, Texas telehealth company selling compounded GLP-1s. Its distinguishing feature is format: compounded semaglutide is offered as an oral/sublingual tablet as well as an injection, at the same published price, which is a real advantage for the substantial number of people whose actual barrier to treatment is the needle rather than the cost.
Pricing is published plainly and is easy to check: $299/month for compounded semaglutide in either format, and $399/month for compounded tirzepatide, both including free two-day shipping and follow-ups with what Willow calls its Care Team. Third-party reporting indicates tirzepatide is not flat — around $499/month at 10mg and 12.5mg and $524/month at 15mg — so the $399 figure is a starting dose price rather than what you will pay at maintenance.
The reason we have marked this provider down is the service record rather than the pricing. Customer reviews cluster on delayed support responses, difficulty cancelling and billing disputes, and roughly a third of reviews on the main review platform are one-star. Willow is also BBB-listed but not BBB accredited.
How the Program Works
- Consultation process
- Online intake reviewed by a US-licensed clinician, with Willow advertising same-day prescription approval.
- Eligibility
- Clinician-assessed at intake. Willow does not publish a BMI threshold. It also does not serve every state — third-party sources put coverage at around 34 states, and the states excluded from its programme include Alabama, Alaska, Arkansas, Delaware, Kansas, Louisiana, Maine, Massachusetts, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, Tennessee, Utah, Vermont, West Virginia and Wyoming. Confirm your own state at sign-up.
- Provider involvement
- US-licensed clinicians review, prescribe and adjust the plan, with follow-ups included in the price. Willow does not name a medical director or publish who supervises prescribing.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- Compounded medication from licensed US compounding pharmacies. Willow does not name them, and states plainly on its own product pages that it "is not the compounding manufacturer".
- Shipping frequency
- Monthly delivery, with free two-day shipping advertised on both the semaglutide and tirzepatide pages.
- Support services
- Follow-up care from the Willow Care Team and advertised 24/7 support. Customer reviews dispute how responsive this is in practice, describing waits of weeks for replies and templated responses to complaints.
Willow Pricing
- Membership fee
- None. The monthly price covers the consultation, medication, shipping and follow-ups.
- Medication fee
- Willow publishes $299/month for compounded semaglutide, in either the injectable or oral tablet format, and $399/month for compounded tirzepatide. Both include free two-day shipping.
- Cancellation policy
- Not published. We could not find cancellation terms on Willow's site, and difficulty cancelling is one of the two most common complaints against the company. Get the terms in writing before you subscribe.
- Refund policy
- Not published. Compounded medication is generally non-returnable once dispensed regardless of provider.
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- HSA / FSA
- Willow states its treatments are HSA/FSA eligible. Confirm with your plan administrator.
Pricing details worth knowing
- Tirzepatide is not flat-priced. Third-party reporting puts it at roughly $499/month for 10mg and 12.5mg and $524/month at 15mg, so budget for the maintenance dose rather than the $399 entry figure.
- Semaglutide is flat at $299 across both formats, which is the more attractive half of the price list.
- $299 is well above the cheapest compounded providers — Ondra Health publishes $96/month and Trimi $99/month annually. You are paying a premium for the oral option and fast approval.
- Willow does not publish cancellation or refund terms anywhere we could find, which matters given that billing and cancellation are the dominant complaint themes against it.
- Willow states its medication is HSA/FSA eligible on its product pages.
Prices change. Every figure above was taken from Willow's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- Oral/sublingual semaglutide at the same $299 price as the injection — a genuine option if needles are the barrier
- Semaglutide pricing is flat across formats and published clearly
- Free two-day shipping and follow-up care included at both price points
- Same-day prescription approval advertised, and the intake is quick
- States openly on its own product pages that it is not the compounding manufacturer and that compounded medication is not FDA-approved
Cons
- Support is the weak point — reviews describe waits of weeks and templated replies, and about a third of reviews are one-star
- Cancellation and refund terms are not published anywhere we could find
- Tirzepatide climbs with dose to a reported $524/month at 15mg
- $299 is roughly three times the cheapest published compounded semaglutide
- BBB-listed but not BBB accredited
- The oral tablet is compounded sublingual semaglutide, not Rybelsus, and no published trial has evaluated it for weight loss
Who Willow May Be Best For
People for whom injections are the actual barrier, and who are willing to pay a premium to avoid them
Anyone who wants a fast, simple start with one published number and no membership fee
Patients on a starting tirzepatide dose who do not expect to titrate to 15mg
Limitations
The oral tablet is not an FDA-approved oral GLP-1. Wegovy tablets and Foundayo are, they have trial evidence behind them, and NovoCare publishes the Wegovy pill at $149/month — less than half what Willow charges for a compounded copy.
Get cancellation terms in writing before subscribing. They are unpublished, and cancellation problems are a recurring complaint.
Price your maintenance tirzepatide dose, not the $399 headline.
Willow does not operate in every state — check yours before starting an intake.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Willow — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Willow
NovoCare Pharmacy
FDA-approved oral Wegovy at $149/mo — half the price of Willow's compounded tablet, with trial evidence behind it
Read review →Henry Meds
Also offers compounded oral and sublingual formats, with a longer operating record
Read review →Ondra Health
Far cheaper at $96/mo and names all five of its compounding pharmacies, if injections are acceptable
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Willow for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
Does Willow offer a GLP-1 pill?
Yes — compounded semaglutide as an oral/sublingual tablet, at the same $299/month as the injection. Be clear about what it is: a compounded sublingual formulation, not Rybelsus and not the FDA-approved Wegovy tablet. No published clinical trial has evaluated compounded sublingual semaglutide for weight loss, so the evidence supporting the injectable does not transfer to it. If an oral GLP-1 is what you want, NovoCare publishes the FDA-approved Wegovy pill at $149/month.
How much does Willow cost?
Willow publishes $299/month for compounded semaglutide in either format and $399/month for compounded tirzepatide, both including free two-day shipping and follow-up care, with no separate membership fee. Tirzepatide rises with dose — third-party reporting puts it at around $499/month for 10mg and 12.5mg and $524/month at 15mg — so the number that matters for tirzepatide is your maintenance dose price, not the entry figure.
Is Willow legitimate?
It is a real telehealth company based in Austin, Texas, prescribing through US-licensed clinicians and dispensing through licensed compounding pharmacies, and it discloses on its own pages that it is not the compounding manufacturer and that compounded medication is not FDA-approved. That disclosure is better than many competitors manage. The concern is service quality rather than legitimacy: it is BBB-listed but not accredited, and about a third of its reviews on the main consumer review platform are one-star, concentrated on support delays and billing.
Can I cancel Willow at any time?
Willow does not publish cancellation terms that we could find, which is a problem given that cancellation difficulty is among the most frequent complaints against it. Before subscribing, ask support in writing how to cancel, what notice is required and when your next billing date falls — and keep the reply.
Is Willow available in my state?
Not necessarily. Willow does not serve all fifty states; third-party sources put its coverage at around 34. States excluded from its programme include Alabama, Alaska, Arkansas, Delaware, Kansas, Louisiana, Maine, Massachusetts, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, Tennessee, Utah, Vermont, West Virginia and Wyoming. State rules for compounded medication change frequently, so confirm at sign-up rather than relying on any published list.
Who should not use Willow?
Anyone shopping primarily on price — this is roughly three times the cheapest published compounded semaglutide. Anyone who expects to titrate tirzepatide to a high dose. Anyone who wants an FDA-approved oral product rather than a compounded one. Separately, GLP-1s are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Common side effects include nausea, vomiting, diarrhoea and constipation during titration. A licensed clinician who knows your history should make that call.
The Verdict
Willow sells compounded semaglutide as an injection or an oral tablet at a published $299/month, and compounded tirzepatide from $399/month. The oral route at a flat price is a genuine draw for anyone blocked by needles. The service behind it is the problem: customer reviews concentrate heavily on slow support and billing, and roughly a third are one-star.
Opens Willow's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Willow stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from Willow's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Willow does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- startwillow.com/compound-semaglutide — $299/mo, free two-day shipping, HSA/FSA eligibility, and the statement that Willow "is not the compounding manufacturer" (checked August 7, 2026)
- startwillow.com/compound-tirzepatide — $399/mo base price, free shipping, 24/7 support and Care Team follow-ups (checked August 7, 2026)
- Third-party reporting on dose-tiered tirzepatide pricing ($499 at 10mg and 12.5mg, $524 at 15mg), Austin HQ, and coverage of roughly 34 states
- Trustpilot — score in the mid-3s with roughly a third of reviews at one star, concentrated on support delays, billing and cancellation; Willow is BBB-listed but not BBB accredited
- Willow's own product pages state that compounded medications are not approved by the FDA and that no clinical trials have evaluated its specific formulations
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.